✦ LIBER ✦

Phase II multicentre randomised study of docetaxel plus epirubicin vs 5-fluorouracil plus epirubicin and cyclophosphamide in metastatic breast cancer

✍ Scribed by Bonneterre, J; Dieras, V; Tubiana-Hulin, M; Bougnoux, P; Bonneterre, M-E; Delozier, T; Mayer, F; Culine, S; Dohoulou, N; Bendahmane, B

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicentric phase II trial of gemcitabi

✍ Cappuzzo, F; Mazzoni, F; Gennari, A; Donati, S; Salvadori, B; Orlandini, C; Cett 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 90 KB

Phase II multicentre study of docetaxel

✍ Lortholary, A; Delozier, T; Monnier, A; Bourgeois, H; Bougnoux, P; Tubiana-Mathi 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 101 KB

Docetaxel plus epirubicin is a highly ac

✍ Serafín Morales; Antonio Lorenzo; Manuel Ramos; Pedro Ballesteros; Miguel Méndez 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 196 KB

Phase II Study of Neo-adjuvant Gemcitabi

✍ Juan Alejandro Silva; Mario Pérez; Samuel Rivera; Guillermo Olivares; Victor Lir 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB

Randomised phase II evaluation of irinot

✍ Moehler, M; Eimermacher, A; Siebler, J; Höhler, T; Wein, A; Menges, M; Flieger, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 130 KB

Bi-weekly chemotherapy with cisplatin, e

✍ Alessandra Felici; Paolo Carlini; Enzo Maria Ruggeri; Teresa Gamucci; Camillo Fr 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 203 KB